FoliuMed
Bernhard Gilb is currently the Head of Quality Germany at FoliuMed since April 2022. Prior to this role, Bernhard served as the Head of Quality Unit at Fidelio Healthcare Limburg GmbH from August 2019 to April 2022. Bernhard also worked as a Berater at Bernhard Gilb QM Beratung from November 2018 to August 2019. With a background in chemistry and extensive experience in quality control, Bernhard has held various leadership roles such as Head of global QC, Head of Quality Unit, and Managing Director in companies like Aenova Group, Sercona GmbH, and HWI pharma services GmbH. Bernhard holds a Dipl. Ing. (FH) in Chemie from Fachhochschule Mannheim, along with several other degrees in natural sciences and chemistry.
This person is not in any teams
This person is not in any offices
FoliuMed
FoliuMed is a producer of pharma-grade cannabis extracts for the medical cannabis and wellness markets. We grow proprietary CBD and THC strains at our Colombian farm and convert them into active pharmaceutical ingredients and medical cannabis products at the EU-GMP certified facility of our JV partners Fidelio in Germany. Our business is built around 3 major principles: 1. Affordability. Cannabis is too expensive and our low cost cultivation in Colombia allows us to offer products at a fraction of today's price. 2. Oral administration forms. European doctors will not prescribe cannabis flowers once they can access safer alternatives like extracts, capsules or sprays which we co-develop with our German partners. 3. Pharma-grade quality. We grow and extract our own cannabis in Colombia under the EU-GMP quality guidelines of Fidelio.